I expect them to clarify what, if anything, they still need to do to complete the GVHD resubmission, and when they expect to do that. If they are waiting on FDA to tell them that, they should at least let us know as much and not leave us here speculating.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.015(1.57%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 96.0¢ | 97.0¢ | 91.5¢ | $1.266M | 1.358M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 74419 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 150 | 4 |
View Market Depth
| Last trade - 10.53am 29/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |